Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent
complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age …

Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a
problem with significant global health impact. Major advances in diagnostics, technology …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

The target audience for the Standards of Care includes primary care physicians,
endocrinologists, nurse practitioners, physician associates/assistants, pharmacists …

Primary diabetes care and diabetic retinopathy (DR) screening persist as major public
health challenges due to a shortage of trained primary care physicians (PCPs), particularly …

The blood–retina barrier (BRB) is the term used to define the properties of the retinal
capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation …

Purpose To compare the efficacy and safety of brolucizumab with aflibercept in patients with
diabetic macular edema (DME). Design Double-masked, 100-week, multicenter, active …

Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide.
Since DR was first recognized as an important complication of diabetes, there have been …

The neuro-ocular effects of long-duration spaceflight have been termed Spaceflight
Associated Neuro-Ocular Syndrome (SANS) and are a potential challenge for future, human …

There remain many unanswered questions on how to assess and treat the pathology and
complications that arise from diabetic retinopathy (DR). Optical coherence tomography …